DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Bioeconomy Capital GP, LLC
Bioeconomy Capital GP, LLC
venture manager, reported GAV $45.0M across 2 vehicles
Importance
12
low
Active deployment
4
low
Emerging
0
low
Completeness
56
elevated
Freshness
100
high
Research priority
4
low
Identity and regulatory footprint
- Headquarters
- Seattle, WAadviserinfo.sec.gov
- Office address
- 3417 EVANSTON AVE N, STE 329, Seattle, WA, 98103adviserinfo.sec.gov
- Business phone
- (415)580-2983adviserinfo.sec.gov
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Jan 11, 2024
- Private funds reported
- 2 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $45.0Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business phone
- (415)580-2983adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
- Sectors
- not stated or not yet read
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series b 100%
Stage at first entry
series b 100%
Sectors
Biotechnology 100%
lead rate 0%follow-on rate 0%new logos, 12 months 1
Funds and vehicles
2 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Bioeconomy Fund 2 | Fund | 2020 adv first reported | Mature | $25.0M Jan 11, 2024 | 2 | unknown | unknown |
| Bioeconomy Fund 1 | Fund | 2015 form d first sale | Harvest | $20.0M Jan 11, 2024 | 2 | $5.0M of $15.0M | Jan 16, 2015 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
4 current, 0 departed
Erik Wehbring
PartnerManaging Director · since Jan 1, 2015
Naveen Jain
PartnerMember · since Jan 1, 2015
Robert Carlson
PartnerManaging Director · since Jan 1, 2015
Spencer Adler
PartnerMember · since Jan 1, 2015
Investments on record
1 edges, 1 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Superluminal Medicines, Inc. | Series B · Series B | participant | unknown | $60.0M | unknown | Sep 3, 2026 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
6 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
5 dated events
- Sep 15, 2026Bioeconomy Capital GP, LLC: INSTITUTIONAL_VC -> MICRO_VC (venture manager, reported GAV $45.0M across 2 vehicles)Classification changedClassificationInferenceno URL
- Sep 12, 2026Bioeconomy Capital GP, LLC: MICRO_VC -> INSTITUTIONAL_VC (venture manager with no reported fund assets yet (scale unknown))Classification changedClassificationInferenceno URL
- Feb 14, 2020Bioeconomy Fund 2 first reported on Form ADV by Bioeconomy Capital GP, LLC (Venture Capital Fund), GAV $13,900,000Fund first reported on Form ADVFundsFactBioeconomy Fund 2SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 26, 2015Bioeconomy Capital GP, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Feb 26, 2015Bioeconomy Fund 1 first reported on Form ADV by Bioeconomy Capital GP, LLC (Venture Capital Fund), GAV $1,400,000Fund first reported on Form ADVFundsFactBioeconomy Fund 1SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 15, 2026Micro VC (confirmed, 95%, cls-1)venture manager, reported GAV $45.0M across 2 vehicles
- Sep 13, 2026Institutional venture firm (confirmed, 70%, cls-1)venture manager with no reported fund assets yet (scale unknown)
- Sep 12, 2026Micro VC (confirmed, 95%, cls-1)venture manager, reported GAV $25.0M across 1 vehicles
Evidence
28 observations from 2 sources